These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8305001)

  • 1. Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomized, controlled trials.
    Atkins D; Psaty BM; Koepsell TD; Longstreth WT; Larson EB
    Ann Intern Med; 1993 Jul; 119(2):136-45. PubMed ID: 8305001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials.
    Bucher HC; Griffith LE; Guyatt GH
    Ann Intern Med; 1998 Jan; 128(2):89-95. PubMed ID: 9441587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials.
    Hebert PR; Gaziano JM; Chan KS; Hennekens CH
    JAMA; 1997 Jul 23-30; 278(4):313-21. PubMed ID: 9228438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol reduction and stroke occurrence: an overview of randomized clinical trials.
    Di Mascio R; Marchioli R; Tognoni G
    Cerebrovasc Dis; 2000; 10(2):85-92. PubMed ID: 10686445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of trials of cholesterol lowering and risk of stroke.
    Hebert PR; Gaziano JM; Hennekens CH
    Arch Intern Med; 1995 Jan; 155(1):50-5. PubMed ID: 7802520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol-lowering interventions and stroke: insights from a meta-analysis of randomized controlled trials.
    De Caterina R; Scarano M; Marfisi R; Lucisano G; Palma F; Tatasciore A; Marchioli R
    J Am Coll Cardiol; 2010 Jan; 55(3):198-211. PubMed ID: 20117400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke.
    Warshafsky S; Packard D; Marks SJ; Sachdeva N; Terashita DM; Kaufman G; Sang K; Deluca AJ; Peterson SJ; Frishman WH
    J Gen Intern Med; 1999 Dec; 14(12):763-74. PubMed ID: 10632823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.
    Vrecer M; Turk S; Drinovec J; Mrhar A
    Int J Clin Pharmacol Ther; 2003 Dec; 41(12):567-77. PubMed ID: 14692706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.
    Collins R; Armitage J; Parish S; Sleight P; Peto R;
    Lancet; 2004 Mar; 363(9411):757-67. PubMed ID: 15016485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials.
    Briel M; Studer M; Glass TR; Bucher HC
    Am J Med; 2004 Oct; 117(8):596-606. PubMed ID: 15465509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does cholesterol lowering prevent stroke?
    Henry RY; Kendall MJ
    J Clin Pharm Ther; 1998 Oct; 23(5):337-44. PubMed ID: 9875681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Sillesen H; Amarenco P; Hennerici MG; Callahan A; Goldstein LB; Zivin J; Messig M; Welch KM;
    Stroke; 2008 Dec; 39(12):3297-302. PubMed ID: 18845807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review on the risk and benefit of different cholesterol-lowering interventions.
    Bucher HC; Griffith LE; Guyatt GH
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):187-95. PubMed ID: 9974397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.
    Berger JS; Roncaglioni MC; Avanzini F; Pangrazzi I; Tognoni G; Brown DL
    JAMA; 2006 Jan; 295(3):306-13. PubMed ID: 16418466
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.